Home › News › Clinical Trials › Archive

Clinical Trial News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

May 2007

May 1

Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack AVI BioPharma Reports Positive Pre-Clinical Influenza Data CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals Peramivir Protects Mice From Lethal H5N1 Infection Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Researchers Urge Caution in Using ESAs for Cancer-Related Anemia

May 2

Lyrica Significantly Reduced Pain and Helped Patients Manage the Symptoms of Fibromyalgia, Data Show Phase III Data on Safinamide in Parkinson’s Disease Presented at American Academy of Neurology 59th Annual Meeting MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen Pediatric Academic Societies' Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV Drug for Treatment of Heart Failure Does Not Improve Survival, Compared to More Widely-used Medication Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic Colorectal Cancer Patients Published Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability Flu Vaccine Used Last Winter Seems to Have Been Less Effective Than Vaccines Used in Previous Years FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms Accera, Inc. Announces Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting St. Jude Study Shows Effectiveness of Peramivir in Prevention of Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection Cethromycin Shown Effective Against Anthrax in Study New Critical Path Report Highlights Research Needed to Foster Generic Drug Development Pluristem to Present Two Scientific Posters at the International Society for Cellular Therapy LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization New Data Shows Once a Day Lamictal XR is Effective in Treating Patients with Partial Seizures

May 3

Once-yearly Reclast Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform Data Presented at the American Academy of Neurology's Annual Meeting Provide Update on Utilization and Safety of Tysabri in Patients with Multiple Sclerosis Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron Quest PharmaTech's Prostate Cancer Program Update Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter Alpharma Presents Positive Pharmacokinetic Study Results of Its Investigational Abuse-Deterrent, Extended-Release Opioid Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine Xanthus Presents Novel Approach for Autoimmune Disease Reversal with Symadex Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting ANX-201 Drug Combination Demonstrates Synergistic Activity Against Human and Bird Flu Viruses Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimer's Disease Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimer's Drug

May 4

Inspire Announces Presentations at 2007 Association for Research in Vision and Ophthalmology Annual Meeting Argos Therapeutics Presents Immunosuppression Data for Soluble CD83 at the American Society of Transplantation Congress 2007 Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis Data to be presented at AAN Meeting -Study results of drug candidate for MS Abbott's Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntington's Disease Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of Neurology Annual Meeting Lux Biosciences' Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007 Independent publication supports the profile of CeNeS phase II compound, CNS 5161 Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device Combination Product - ChronoDose Isotechnika's Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

May 7

IR BioSciences Announces Promising Data from Study of Its Compound Homspera NanoViricides Drugs Found To Be Highly Effective Against Most Recent Strain of the H5N1 Avian Flu Virus Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting Pacgen Announces Positive Results from Phase I/II Trial of Novel Antifungal Drug Early Results of the CellCept Spare the Nephron Study Examine Kidney Function Preterm Infants with Respiratory Distress Syndrome: Incidence Rates of Death when Treated with Surfactant Replacement Therapies OXiGENE Announces a Poster Presentation Highlighting Results from its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study MMD-213) at the 47th Annual Meeting of the Association of Research in Vision and Ophthalmology FDA Advises Manufacturers to Test Glycerin for Possible Contamination Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In Absolute Bioavailability Study Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients Isotechnika Announces Interim Three Month Data from Phase 2b Kidney Transplant Trial

May 8

Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies' Annual Meeting King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at Second International Congress on Neuropathic Pain Data Show FluMist May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published

May 9

Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats FDA Re-Inspection Results in Positive Re-Classification of Guayama Facility Discovery's KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties Palatin Technologies and King Pharmaceuticals Announce Plan To Present Results of Bremelanotide Phase 2b Studies in Men With Erectile Dysfunction Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be Presented at American Thoracic Society International Conference Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's Investigational Drug to Treat Cocaine and Methamphetamine Addiction VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type Disasters; House Urged to Act on Strong Drug Safety Bill

May 10

Repligen Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas New England Journal of Medicine Publishes New Data on Gardasil, Merck's Cervical Cancer Vaccine Gardasil Demonstrates Up to 100% Efficacy Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor AP 12009 to be Presented FDA Announces Results of Investigation Into Illegal Promotion of OxyContin by The Purdue Frederick Company, Inc. GenVec Presents Research on New Ad35 Adenovector at ARVO KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time 2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion

May 14

GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke Oculus Innovative Sciences Microcyn Technology Presented in Poster at European Wound Management Association Conference Global Rabies Treatment May be Possible with NanoViricides Drugs Sciele Pharma Announces Successful Completion of New Sular Formulation Clinical Trial Program BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in Preclinical Studies Nationally Recognized Researchers Provide First Economic Projections of Social Value of Treatments That Delay Onset of Alzheimer's Disease Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace

May 15

Accelreon Pharma's ACE-031Shown to Increase Muscle Mass in Preclinical Studies SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 New Survey Finds Troubling Data on American Asthma Sufferers Gemin X Biotechnologies Announces Publication in Blood of Positive Preclinical Data of Lead Compound in Mantle Cell Lymphoma Boston Scientific Announces Schedule for EuroPcr 2007 Positive results from placebo-controlled phase IIa study in patients suffering from house dust mite allergy Geron Corp. Licensee TA Sciences Announces Proven Anti-Aging Benefits of TA-65, Their Telomerase Activator: Improved Immune Function, Vision, Skin, Male Sexual Function, Well-Being & Energy are Strongest Claims First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer

May 17

Oxford Biomedica Announces That Phase II Results with Hi-8 Mel in Melanoma Will Be Presented at American Association of Immunologists Meeting AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin Cells Have the Ability to Recognize, Transport and Utilize L-ergothioneine (EGT) As A Protector Against Oxidative Damage DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life ProtoKinetix' AAGP Improves Effectiveness of Diabetes Treatment Pro-Pharmaceuticals to Present Abstract at the International Society of Oncodevelopmental Biology and Medicine Conference Salix Pharmaceuticals Previews Digestive Disease Week 2007 Inovio Biomedical's Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials Clinical Trial Data for Perforomist Inhalation Solution to be Presented at ATS on May 20, 2007 BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming Clinical Conferences Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent

May 18

DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp Data Published in The Lancet Show Gardasil was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18 Staphylococcus aureus vaccine development on track ? safe and immunogenic in Phase I clinicaltrials Avant's Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential Migenix to Present Celgosivir Phase II Hepatitis C Results at Digestive Disease Week 2007 Avant’s Typhoid Fever Vaccine Demonstrates Excellent Clinical Potential Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007 American Psychiatric Association Annual Meeting

May 21

Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007) InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive Disease Week Meeting Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma Data Suggest that Pegasys May be an Option in Hepatitis C Patients Unable to Tolerate Peg-Intron New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For 24-hour Blood Pressure Control New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin in Complicated Urinary Tract Infections and Acute Pyelonephritis Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients Dendreon Announces Presentation of Data at American Urological Association Annual Meeting Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data Efficacy and Safety Profile of Basilea's Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril Microbia Announces Positive Phase 2 Results for Its Investigational Compound Linaclotide Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C) Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy CEL-SCI Presents Long-Term Cancer Survival Data With Multikine Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex Alterations in Intestinal Serotonin in Irritable Bowel Syndrome and Dyspepsia FDA Issues Safety Alert on Avandia Pegasys Study Authors Conclude that Patients Successfully Treated for Hepatitis C Can be Considered ''Cured'' Data Suggest Cymbalta Improved Functioning in Patients with Generalized Anxiety Disorder

May 22

Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association Comptroller General Announces Appointments to the Medicare Payment Advisory Commission Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder Organon's Asenapine Effective in a Phase III Study for the Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA Meeting Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants UCB Presents Long-Term CImzia Data in Crohn's Disease New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At Annual Digestive Disease Week Meeting Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week New Analysis of Data Shows Treatment With Abbott's Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohn's Disease Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral Approach to Treating Inflammatory Diseases Auxilium Announces New Data That Show Total Testosterone Blood Levels Increase Significantly Following Switch from AndroGel(R) to Testim(R) BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis Sosei Announces Successful Completion of AD 923 Pharmacokinetic Study in the USA Inovio: DNA delivery technology shows positive human results Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents NCCN Updates Esophageal and Gastric Cancer Guidelines ACC Sanctions Leon Enzo Biochem Individualized Oral Immune Regulation Therapy May Be Effective Approach to Treating Crohn's Disease Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia Abbott Announces Positive Nine-Month Results From the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug Candidate, Sphingomab Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial Results at EuroPCR 2007 Medtronic Announces Positive Nine-Month Results for Endeavor Resolute Next Generation Drug-Eluting Stent at EuroPCR SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus Drug-Eluting Coronary Stent Systems Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting Antipsychotic Iloperidone Results Show Favorable Akathisia Profile New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant

May 23

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting ProtoKinetix's AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007 MIV Therapeutics Announces Renowned Researcher to Detail Milestone Pre-Clinical Results at Prominent International Conference EuroPCR 2007 CytoGenix to Present at 2007 International DNA Vaccines Conference in Spain Vical's Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from 2006 Presented at Digestive Disease Week in Washington, D.C. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007 Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon Neurogen Proprietary Insomnia Compound Data Presented at American Psychiatric Association Annual Meeting Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models New Data Suggests Less Abuse-Related Effects For OROS Methylphenidate CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007) Acusphere Announces Publication on Imagify in the Journal Future Drugs New Data Focuses on Abuse of Stimulant Medication Synta Oncology Candidate STA-4783 Clinical Trial Results to Be Presented at the ASCO Annual Meeting Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

May 24

Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions La Jolla Pharmaceutical Company Reports Riquent Well Tolerated in Three Studies at International Lupus Congress Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents ChemoCentryx Presents Positive Phase 2 Clinical Data for Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007 Conference Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia Inovio Biomedical's DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results Long-term Treatment with Vyvanse (lisdexamfetamine dimesylate), the First Prodrug Stimulant, Demonstrates Significant Efficacy in Children with ADHD RX100 Rescues Life if Administered 3, 6, 12, or Up to 24 Hours After Exposure to Lethal, Whole-Body Radiation! In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, in Reducing Painful Symptoms in Ssri Non- or Partial-responders with Depression Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for the Treatment of Psoriasis Proteolix Announces Interim Clinical Results with Carfilzomib to be Reported at ASCO 2007 Annual Meeting Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO Generex Biotechnology Vaccine Strategy Presented at International Conference in London Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax

May 25

GTx Announces Presentation of Ostarine and Acapodene Data at 2007 ASCO Annual Meeting Iomai Announces Interim Results From Phase 1 Study of Its Patch-Based Vaccine for Seasonal Influenza Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting Clinical Trial Excellence: Shaping Markets Through Early Communication of Clinical Trial Data Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds Iomai to Announce Results From Phase 1 Influenza Trial and Host Webcast Tomorrow Viventia Biotech Reports Final Vicinium Phase I/II Bladder Cancer Data at the American Urological Association Annual Meeting Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study Results at the American Society of Clinical Oncology Annual Meeting Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting

May 29

Onyx Pharmaceuticals Announces an Analyst Briefing New Pfizer Oncology Data Across Numerous Cancer Types to be Presented at ASCO Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos' Bevirimat Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings HepaLife Announces Scientific Presentation of PBS-1 Cell Line at International Influenza Meeting Antidepressant Use May Boost Fracture Risk, From Harvard Women's Health Watch Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research Alfacell and University of Bath Collaborators Identify Structure of Amphinase Mild Asthma, a Revolutionary Therapy from Italian Research Velcade (Bortezomib) for Injection to be Featured at Upcoming American Society of Clinical Oncology Meeting DP-b99 Phase IIb Trial Results to be Presented at the European Stroke Conference Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal

May 30

Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis New Data Highlighting Abraxane as Single Agent and in Combination for the Treatment of Breast, Lung and Ovarian Cancers to Be Presented at ASCO Innovive Pharmaceuticals to Present Interim Data from Phase I Study of INNO-406 at the American Society of Clinical Oncology Annual Meeting Celldex Therapeutics Announces Poster Presentations of Lead Product Candidates at ASCO Annual Meeting Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO Celsion Completes Enrollment in Phase I Liver Cancer Study Introgen's Advexin Demonstrates Clinical Benefit in Inherited Cancer Inovio Biomedical to Present at American Society of Gene Therapy Meeting Array BioPharma to Present Clinical Data at the European League Against Rheumatism (EULAR) Annual Meeting and the 8th World Congress on Inflammation Data from Rexahn Pharmaceuticals' Phase I Trial of RX-0201 (Archexin) to Be Presented at the 43rd American Society of Clinical Oncology Annual Meeting in Chicago

May 31

Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO Annual Meeting Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at the American Headache Society Meeting AMT Presents Positive Results of Phase I/II Study with Lead Product at Annual Meeting of American Society of Gene Therapy Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard Researcher Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference Data Published in the New England Journal of Medicine Showed Torisel Extended Median Overall Survival for Patients with Advanced Renal Cell Carcinoma IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at 2007 ASCO Annual Meeting Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates LifeCycle Pharma Announces Positive Phase I Clinical Results for its Transplantation Product Candidate, LCP-Tacro Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007 Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO New Research Confirms the Benefit of Extended-Release Dipyridamole Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk Patients Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod) Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients Medicure's MEND-CABG Trial Results Published in Peer Reviewed Journal PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics

Clinical Trial Results Archive

2005

April

More News Resources

(web6)